Logo image of MGLD

MARYGOLD COMPANIES INC/THE (MGLD) Stock Fundamental Analysis

USA - NYSEARCA:MGLD - US57403M1045 - Common Stock

1.06 USD
+0.05 (+4.71%)
Last: 10/20/2025, 8:04:02 PM
Fundamental Rating

3

MGLD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. MGLD has a great financial health rating, but its profitability evaluates not so good. MGLD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MGLD had negative earnings in the past year.
In the past year MGLD has reported a negative cash flow from operations.
In multiple years MGLD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MGLD reported negative operating cash flow in multiple years.
MGLD Yearly Net Income VS EBIT VS OCF VS FCFMGLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

With a Return On Assets value of -19.14%, MGLD is not doing good in the industry: 88.14% of the companies in the same industry are doing better.
The Return On Equity of MGLD (-25.32%) is worse than 84.32% of its industry peers.
Industry RankSector Rank
ROA -19.14%
ROE -25.32%
ROIC N/A
ROA(3y)-9.4%
ROA(5y)-1.28%
ROE(3y)-12.26%
ROE(5y)-1.94%
ROIC(3y)N/A
ROIC(5y)N/A
MGLD Yearly ROA, ROE, ROICMGLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

MGLD's Gross Margin of 72.53% is fine compared to the rest of the industry. MGLD outperforms 79.66% of its industry peers.
In the last couple of years the Gross Margin of MGLD has remained more or less at the same level.
MGLD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.41%
GM growth 5Y-0.87%
MGLD Yearly Profit, Operating, Gross MarginsMGLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for MGLD has been increased compared to 1 year ago.
The number of shares outstanding for MGLD has been increased compared to 5 years ago.
The debt/assets ratio for MGLD is higher compared to a year ago.
MGLD Yearly Shares OutstandingMGLD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
MGLD Yearly Total Debt VS Total AssetsMGLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

An Altman-Z score of 4.80 indicates that MGLD is not in any danger for bankruptcy at the moment.
MGLD's Altman-Z score of 4.80 is amongst the best of the industry. MGLD outperforms 84.75% of its industry peers.
MGLD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.8
ROIC/WACCN/A
WACCN/A
MGLD Yearly LT Debt VS Equity VS FCFMGLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.87 indicates that MGLD has no problem at all paying its short term obligations.
MGLD has a Current ratio of 2.87. This is amongst the best in the industry. MGLD outperforms 80.51% of its industry peers.
MGLD has a Quick Ratio of 2.57. This indicates that MGLD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.57, MGLD is in the better half of the industry, outperforming 75.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.57
MGLD Yearly Current Assets VS Current LiabilitesMGLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MGLD have decreased strongly by -38.59% in the last year.
The Revenue has decreased by -8.17% in the past year.
Measured over the past years, MGLD shows a small growth in Revenue. The Revenue has been growing by 2.43% on average per year.
EPS 1Y (TTM)-38.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.61%
Revenue 1Y (TTM)-8.17%
Revenue growth 3Y-7.28%
Revenue growth 5Y2.43%
Sales Q2Q%-12.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGLD Yearly Revenue VS EstimatesMGLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MGLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGLD Price Earnings VS Forward Price EarningsMGLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGLD Per share dataMGLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MGLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARYGOLD COMPANIES INC/THE

NYSEARCA:MGLD (10/20/2025, 8:04:02 PM)

1.06

+0.05 (+4.71%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-19 2025-09-19
Earnings (Next)11-06 2025-11-06
Inst Owners0.46%
Inst Owner Change0%
Ins Owners7.65%
Ins Owner Change0.27%
Market Cap45.39M
AnalystsN/A
Price TargetN/A
Short Float %0.31%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.51
P/FCF N/A
P/OCF N/A
P/B 1.97
P/tB 2.33
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.7
BVpS0.54
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.14%
ROE -25.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.53%
FCFM N/A
ROA(3y)-9.4%
ROA(5y)-1.28%
ROE(3y)-12.26%
ROE(5y)-1.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.41%
GM growth 5Y-0.87%
F-Score2
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.15%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.87
Quick Ratio 2.57
Altman-Z 4.8
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)11.6%
Cap/Depr(5y)11.12%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.17%
Revenue growth 3Y-7.28%
Revenue growth 5Y2.43%
Sales Q2Q%-12.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.68%
OCF growth 3YN/A
OCF growth 5YN/A